OROFAR lozenges 24

 https://www.docsimon.cz/_iservice/ord_stat.php

Application form: tablets, capsules

Indication group: otorhinolaryngologicals

Active substance: Benzoxonii chloridum 1 mg, Lidocaini hydrochloridum monohydricum 1 mg

minimum amount for dispatch: Orofar contains a substance effective against infection and a substance which causes desensitisation (anaesthetic). It is used for the treatment of inflammations of the oral cavity and the pharynx. Orofar is available in form of lozenges, spray and solution for rinsing or gargling.

EAN: 8596149002149

Manufacturer: Novartis s.r.o., Prague, Czech Republic, www.novartis.com